Literature DB >> 19951319

Transfusion management of patients with sickle cell disease: the continuing dilemma.

Karen E King, R Sue Shirey.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19951319     DOI： 10.1111/j.1537-2995.2009.02527.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  7 in total

1.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Authors:  Elliott Vichinsky; Lynne Neumayr; Sean Trimble; Patricia J Giardina; Alan R Cohen; Thomas Coates; Jeanne Boudreaux; Ellis J Neufeld; Kristy Kenney; Althea Grant; Alexis A Thompson
Journal:  Transfusion       Date:  2013-07-25       Impact factor: 3.157

2.  Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.

Authors:  Weili Bao; Hui Zhong; Xiaojuan Li; Margaret T Lee; Joseph Schwartz; Sujit Sheth; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2011-09-26       Impact factor: 10.047

3.  Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

Authors:  Scott T Miller; Hae-Young Kim; Debra L Weiner; Carrie G Wager; Dianne Gallagher; Lori A Styles; Carlton D Dampier; Susan D Roseff
Journal:  Transfusion       Date:  2012-07-13       Impact factor: 3.157

4.  Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; R Sue Shirey; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2014-02-27       Impact factor: 3.157

5.  Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; R Sue Shirey; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2013-05-21       Impact factor: 3.157

6.  Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.

Authors:  Marion E Reid; Christine Halter Hipsky; Kim Hue-Roye; Carolyn Hoppe
Journal:  Blood Cells Mol Dis       Date:  2013-12-02       Impact factor: 3.039

7.  Management of immigration and pregnancy screening in northeastern Italy.

Authors:  Giorgio Tamaro; Sergio Parco
Journal:  Risk Manag Healthc Policy       Date:  2011-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.